D. A. Ollendorf

Surrogate endpoints in cost-effectiveness analysis for use in health technology assessment – a qualitative analysis

Abstract Objectives The use of surrogate endpoints poses challenges to health technology assessment (HTA) agencies and payers when informing the clinical and cost-effectiveness of health technologies. Decision makers often need to make recommendations in the absence of well-established evidence on their validation, par...